Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,563 | 379 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $941.16 | 74 | $0 (2024) |
| Novo Nordisk Inc | $932.68 | 84 | $0 (2024) |
| Lilly USA, LLC | $799.89 | 56 | $0 (2024) |
| GlaxoSmithKline, LLC. | $244.93 | 14 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $233.73 | 12 | $0 (2024) |
| Lundbeck LLC | $216.84 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $211.28 | 12 | $0 (2024) |
| Amgen Inc. | $186.64 | 16 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $171.72 | 10 | $0 (2024) |
| Corium, LLC | $157.87 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,588 | 106 | ABBVIE INC. ($260.60) |
| 2023 | $1,461 | 92 | Novo Nordisk Inc ($249.33) |
| 2022 | $1,135 | 81 | ABBVIE INC. ($241.34) |
| 2021 | $1,379 | 100 | Novo Nordisk Inc ($245.61) |
All Payment Transactions
379 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Oncology | ||||||
| 12/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Inflammation | ||||||
| 12/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $2.58 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/14/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: PSYCHIATRY | ||||||
| 10/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/17/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.91 | General |
| Category: NEUROLOGY | ||||||
| 10/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.60 | General |
| Category: Inflammation | ||||||
| 09/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Diabetes | ||||||
| 09/20/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $14.54 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 09/19/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $0.79 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: Inflammation | ||||||
| 09/13/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 332 | 878 | $129,502 | $36,999 |
| 2022 | 3 | 97 | 171 | $37,484 | $12,046 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 349 | $77,478 | $22,723 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 122 | $18,788 | $5,423 | 28.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 121 | $11,374 | $3,590 | 31.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $14,112 | $3,327 | 23.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $2,607 | $1,386 | 53.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 53 | $1,855 | $344.05 | 18.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 28 | 28 | $1,008 | $165.30 | 16.4% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 14 | 59 | $885.00 | $20.96 | 2.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 18 | 60 | $900.00 | $16.66 | 1.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 22 | 33 | $495.00 | $2.65 | 0.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 45 | 81 | $17,982 | $6,048 | 33.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 59 | $9,086 | $3,020 | 33.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $10,416 | $2,978 | 28.6% |
About William Boston
William Boston is a Family Health healthcare provider based in Greenwell Springs, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2014. The National Provider Identifier (NPI) number assigned to this provider is 1487063590.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, William Boston has received a total of $5,563 in payments from pharmaceutical and medical device companies, with $1,588 received in 2024. These payments were reported across 379 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($5,563).
As a Medicare-enrolled provider, Boston has provided services to 429 Medicare beneficiaries, totaling 1,049 services with total Medicare billing of $49,044. Data is available for 2 years (2022–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Family Health
- Location Greenwell Springs, LA
- Active Since 08/04/2014
- Last Updated 08/21/2024
- Taxonomy Code 364SF0001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1487063590
Products in Payments
- Ozempic (Drug) $500.63
- VRAYLAR (Drug) $497.33
- MOUNJARO (Drug) $377.84
- QULIPTA (Drug) $334.22
- JARDIANCE (Drug) $254.11
- TRELEGY ELLIPTA (Drug) $244.93
- REXULTI (Drug) $208.97
- Rybelsus (Drug) $206.12
- TRULICITY (Drug) $198.65
- TRINTELLIX (Drug) $167.76
- Otezla (Drug) $163.36
- Azstarys (Drug) $157.87
- Wegovy (Drug) $154.85
- VYEPTI (Biological) $130.94
- FARXIGA (Drug) $111.12
- NURTEC ODT (Drug) $109.29
- AJOVY (Biological) $106.59
- EMGALITY (Drug) $96.94
- Xeomin (Biological) $95.71
- Dayvigo (Drug) $91.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.